|

Infusion of iNKT cells and CD8+T cells Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Shanghai Public Health Clinical Center1

Indications

  • Liver Disease1
  • Renal Cell Carcinoma1
  • Pancreas Cancer1
  • Liver Cancer1
  • Gastric Cancer1

Other1 trial

Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.